Evidence boundary from the checked abstract: The results of this study also suggest that tyrosine is a relatively benign treatment at this dose.
The results of this study also suggest that tyrosine is a relatively benign treatment at this dose.
The effects of tyrosine on cognitive performance during extended wakefulness.
Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.